D-0790-2017 Class III Terminated
FDA drug recall D-0790-2017 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Mar 17, 2017 and is designated Class III. Reason for recall: Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate. The recall status is terminated (terminated Aug 24, 2021). Affected quantity: 7,776 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- May 24, 2017
- Initiation Date
- Mar 17, 2017
- Termination Date
- Aug 24, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,776 tubes
Product description
Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1254-3
Reason for recall
Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
Distribution pattern
U.S. Nationwide
Code information
Lot #: D301311473, D301411473, Exp 3/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0790-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026